Malignant melanoma with in-transit metastases refractory to programmed cell death-1 inhibitor successfully treated with local interferon-β injections: A case report

In-transit metastases (ITMs) in patients with malignant melanoma (MM) are associated with poor prognosis and a worse disease burden compared with MM without ITMs. A substantial population of patients with ITMs show no or only poor responses to newly developed therapies, such as immune checkpoint inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahara, Yui, Kan, Takanobu, Teshima, Yoshie, Matsubara, Daiki, Takahagi, Shunsuke, Tanaka, Akio, Hide, Michihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375038/
https://www.ncbi.nlm.nih.gov/pubmed/34462667
http://dx.doi.org/10.3892/mco.2021.2374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375038/
https://www.ncbi.nlm.nih.gov/pubmed/34462667
http://dx.doi.org/10.3892/mco.2021.2374

Ejemplares similares